UsA2’s 2020 Annual Report Chronicles a Decade of Impact

In the 10 years since we founded UsAgainstAlzheimer’s, we have seen enormous progress in the fight to stop Alzheimer’s disease. Our 2020 Annual Report features milestones from this past year as well as highlights from a decade of impact. Last month, after our Annual Report was completed, the Food and Drug Administration (FDA) approved the first disease-modifying therapy and the first-ever therapy approved for mild cognitive impairment. This approval of Aduhelm is a true breakthrough moment in Alzheimer’s history, providing patients, for the first time, the chance to consider a therapy that slows the progression of their Alzheimer’s disease. While

New WEF-CEOi initiative is a promising step forward

A new global multi-stakeholder partnership being launched is a promising – and necessary – step forward in the global effort to effectively combat Alzheimer’s disease and dementia.

Brain Health Redux

UsAgainstAlzheimer’s continues urgent call for a new approach to brain health across the lifespan

Yesterday's Dream is Today's Reality

Trish and I were married for 49 years. April 17 marked the second anniversary of her passing -- from a heart attack. I know, in her unique humor that animated our lives and in her writing for "Designing Women", "Family Ties" and "Kate and Allie", she is probably saying, "George, we picked the wrong disease." In truth, curing Alzheimer's was always her passion. Her fight -- our shared fight -- was for her mother. We decided not to stand aside and leave this to somebody else but rather to challenge this disease ourselves. So, in 2010, we founded UsAgainstAlzheimer’s (with

Opinion: We can accelerate a cure for Alzheimer's

Reposted from The Hill. By George Vradenburg Since the first cases were diagnosed in 1981, 1.8 million Americans have been diagnosed with HIV/AIDS. A positive diagnosis was once thought to be a death sentence and the disease was considered one of the greatest public health crises ever. In response, the federal government poured massive resources into developing treatments and now, thanks to pharmacological and other research, HIV/AIDS is considered a chronic but no longer life-threatening condition. By comparison, 5.8 million Americans today are battling Alzheimer’s disease, with a new case being diagnosed every 65 seconds. By 2050, the number of